Carisma Therapeutics Faces Delisting Notice
Ticker: CARM · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1485003
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: CARM
TL;DR
CARM is getting kicked off Nasdaq. Big trouble.
AI Summary
Carisma Therapeutics Inc. filed an 8-K on April 16, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's stock was previously traded under the ticker symbol 'CARM' on the Nasdaq Capital Market.
Why It Matters
This filing indicates potential delisting from the Nasdaq, which could significantly impact the stock's liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded on a major exchange, posing a severe risk to its operations and shareholder value.
Key Players & Entities
- Carisma Therapeutics Inc. (company) — Registrant
- Nasdaq Capital Market (company) — Exchange where stock was traded
- CARM (company) — Stock ticker symbol
FAQ
What specific rule or standard has Carisma Therapeutics Inc. failed to satisfy for continued listing on the Nasdaq Capital Market?
The filing does not specify the exact rule or standard that Carisma Therapeutics Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is April 10, 2025.
What was Carisma Therapeutics Inc.'s former company name?
Carisma Therapeutics Inc. was formerly known as Sesen Bio, Inc. and Eleven Biotherapeutics, Inc.
In which state was Carisma Therapeutics Inc. incorporated?
Carisma Therapeutics Inc. was incorporated in Delaware.
What is the business address of Carisma Therapeutics Inc.?
The business address of Carisma Therapeutics Inc. is 3675 Market Street, Suite 401, Philadelphia, PA 19104.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding Carisma Therapeutics Inc. (CARM).